Literature DB >> 18191026

Casein kinase 1 alpha associates with the tau-bearing lesions of inclusion body myositis.

Theresa J Kannanayakal1, Jerry R Mendell, Jeff Kuret.   

Abstract

Inclusion body myositis and Alzheimer's disease are age-related disorders characterized in part by the appearance of intracellular lesions composed of filamentous aggregates of the microtubule-associated protein tau. Abnormal tau phosphorylation accompanies tau aggregation and may be an upstream pathological event in both diseases. Enzymes implicated in tau hyperphosphorylation in Alzheimer's disease include members of the casein kinase 1 family of phosphotransferases, a group of structurally related protein kinases that frequently function in tandem with the ubiquitin modification system. To determine whether casein kinase 1 isoforms associate with degenerating muscle fibers of inclusion body myositis, muscle biopsy sections isolated from sporadic disease cases were subjected to double-label fluorescence immunohistochemistry using selective anti-casein kinase 1 and anti-phospho-tau antibodies. Results showed that the alpha isoform of casein kinase 1, but not the delta or epsilon isoforms, stained degenerating muscle fibers in all eight inclusion body myositis cases examined. Staining was almost exclusively localized to phospho-tau-bearing inclusions. These findings, which extend the molecular similarities between inclusion body myositis muscle and Alzheimer's disease brain, implicate casein kinase 1 alpha as one of the phosphotransferases potentially involved in tau hyperphosphorylation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18191026      PMCID: PMC2359895          DOI: 10.1016/j.neulet.2007.11.066

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  48 in total

1.  The casein kinase I family in Wnt signaling.

Authors:  R M McKay; J M Peters; J M Graff
Journal:  Dev Biol       Date:  2001-07-15       Impact factor: 3.582

2.  Rimmed vacuoles and the added value of SMI-31 staining in diagnosing sporadic inclusion body myositis.

Authors:  M F van der Meulen; J E Hoogendijk; K G Moons; H Veldman; U A Badrising; J H Wokke
Journal:  Neuromuscul Disord       Date:  2001-07       Impact factor: 4.296

3.  Casein kinase I associates with members of the centaurin-alpha family of phosphatidylinositol 3,4,5-trisphosphate-binding proteins.

Authors:  T Dubois; P Kerai; E Zemlickova; S Howell; T R Jackson; K Venkateswarlu; P J Cullen; A B Theibert; L Larose; P J Roach; A Aitken
Journal:  J Biol Chem       Date:  2001-03-02       Impact factor: 5.157

4.  Aberrant expression of cyclin-dependent kinase 5 in inclusion body myositis.

Authors:  S Nakano; I Akiguchi; S Nakamura; H Satoi; S Kawashima; J Kimura
Journal:  Neurology       Date:  1999-11-10       Impact factor: 9.910

5.  Inclusion body myositis: expression of extracellular signal-regulated kinase and its substrate.

Authors:  S Nakano; A Shinde; S Kawashima; S Nakamura; I Akiguchi; J Kimura
Journal:  Neurology       Date:  2001-01-09       Impact factor: 9.910

6.  Casein kinase I-dependent phosphorylation within a PEST sequence and ubiquitination at nearby lysines signal endocytosis of yeast uracil permease.

Authors:  C Marchal; R Haguenauer-Tsapis; D Urban-Grimal
Journal:  J Biol Chem       Date:  2000-08-04       Impact factor: 5.157

7.  Cyclin-dependent kinase 5 colocalizes with phosphorylated tau in human inclusion-body myositis paired-helical filaments and may play a role in tau phosphorylation.

Authors:  G M Wilczynski; W K Engel; V Askanas
Journal:  Neurosci Lett       Date:  2000-10-20       Impact factor: 3.046

8.  Akr1p and the type I casein kinases act prior to the ubiquitination step of yeast endocytosis: Akr1p is required for kinase localization to the plasma membrane.

Authors:  Y Feng; N G Davis
Journal:  Mol Cell Biol       Date:  2000-07       Impact factor: 4.272

9.  Sites of phosphorylation in tau and factors affecting their regulation.

Authors:  B H Anderton; J Betts; W P Blackstock; J P Brion; S Chapman; J Connell; R Dayanandan; J M Gallo; G Gibb; D P Hanger; M Hutton; E Kardalinou; K Leroy; S Lovestone; T Mack; C H Reynolds; M Van Slegtenhorst
Journal:  Biochem Soc Symp       Date:  2001

10.  Ets-2 repressor factor silences extrasynaptic utrophin by N-box mediated repression in skeletal muscle.

Authors:  Kelly J Perkins; Utpal Basu; Murat T Budak; Caroline Ketterer; Santhosh M Baby; Olga Lozynska; John A Lunde; Bernard J Jasmin; Neal A Rubinstein; Tejvir S Khurana
Journal:  Mol Biol Cell       Date:  2007-05-16       Impact factor: 4.138

View more
  9 in total

1.  Generation and characterization of a tractable C. elegans model of tauopathy.

Authors:  Joshua C Russell; Haoyi Lei; Rahul K Chaliparambil; Sarah Fish; Susan M Markiewicz; Ting-I Lee; Anushka Noori; Matt Kaeberlein
Journal:  Geroscience       Date:  2021-09-18       Impact factor: 7.581

Review 2.  The ubiquitin proteasome system in neuropathology.

Authors:  Norman L Lehman
Journal:  Acta Neuropathol       Date:  2009-07-14       Impact factor: 17.088

Review 3.  Inclusion body myositis: review of recent literature.

Authors:  Steven A Greenberg
Journal:  Curr Neurol Neurosci Rep       Date:  2009-01       Impact factor: 5.081

4.  Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome.

Authors:  Fei Liu; Zhihou Liang; Jerzy Wegiel; Yu-Wen Hwang; Khalid Iqbal; Inge Grundke-Iqbal; Narayan Ramakrishna; Cheng-Xin Gong
Journal:  FASEB J       Date:  2008-05-28       Impact factor: 5.191

Review 5.  Inclusion body myositis: a view from the Caenorhabditis elegans muscle.

Authors:  Daniela L Rebolledo; Alicia N Minniti; Paula M Grez; Ricardo Fadic; Rebecca Kohn; Nibaldo C Inestrosa
Journal:  Mol Neurobiol       Date:  2008-09-05       Impact factor: 5.590

Review 6.  Updates on the Immunopathology in Idiopathic Inflammatory Myopathies.

Authors:  Akinori Uruha; Hans-Hilmar Goebel; Werner Stenzel
Journal:  Curr Rheumatol Rep       Date:  2021-07-01       Impact factor: 4.592

7.  Widespread protein aggregation as an inherent part of aging in C. elegans.

Authors:  Della C David; Noah Ollikainen; Jonathan C Trinidad; Michael P Cary; Alma L Burlingame; Cynthia Kenyon
Journal:  PLoS Biol       Date:  2010-08-10       Impact factor: 8.029

8.  Network screening of Goto-Kakizaki rat liver microarray data during diabetic progression.

Authors:  Huarong Zhou; Shigeru Saito; Guanying Piao; Zhi-Ping Liu; Jiguang Wang; Katsuhisa Horimoto; Luonan Chen
Journal:  BMC Syst Biol       Date:  2011-06-20

9.  Intrinsically aggregation-prone proteins form amyloid-like aggregates and contribute to tissue aging in Caenorhabditis elegans.

Authors:  Sara Wagner-Valladolid; Amberley D Stephens; Chaolie Huang; Raimund Jung; Chetan Poudel; Tessa Sinnige; Marie C Lechler; Nicole Schlörit; Meng Lu; Romain F Laine; Claire H Michel; Michele Vendruscolo; Clemens F Kaminski; Gabriele S Kaminski Schierle; Della C David
Journal:  Elife       Date:  2019-05-03       Impact factor: 8.140

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.